Page results
-
More than 800 patients on waiting lists for Ear, Nose and Throat appointments across North Central London seen in two days during ENT surgery ‘super-weekend’
-
In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Wednesday 28 January 2026.
-
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.
-
A multiple sclerosis (MS) patient in the UK is the first to receive CAR T cell therapy in a UCLH clinical trial testing whether this personalised treatment may slow or even halt the progression of the disease.
-
Young cancer patients and staff couldn’t believe their eyes when David Beckham paid a visit to the University College Hospital Macmillan Cancer Centre earlier this year.
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
-
To enable us to provide a quick response when you need it most, we have developed these Frequently Asked Questions (FAQs). We kindly ask you to read through these before contacting our team as you may find the answer to your question here.
